Myeloma UK

Myeloma UK is a registered education nonprofit based in Edinburgh, Scotland, United Kingdom. It is registered with the Charity Commission for England and Wales. It was founded in 1997 and has been operating for 29 years. Its registration number is SC026116. GiveRadar's Integrity Assessment for the organization is 41/100, which reflects how much public information is available, not whether the charity is legitimate. The organization reports £5M in annual revenue.

Myeloma UK's official registration number is SC026116, as recorded in the national registry of United Kingdom.

Myeloma UK has a GiveRadar Integrity Assessment of 41/100. This score combines five components: Registration (20 pts), Financial Transparency (30 pts), Governance (20 pts), Contact Availability (10 pts), and Data Recency (20 pts), with negative adjustments for any red flags. A score of 41 ('Partial transparency') means some public data is on file but key signals are missing - worth a closer look before donating. For comparison, the average integrity assessment for education charities in United Kingdom is 86/100.

Myeloma UK is located in Edinburgh, Scotland, United Kingdom. The organization was established in 1997 and has been active for 29 years.

Based on official tax filings, Myeloma UK has £5M in annual revenue. It allocates 67% of expenses to programs and services. This is below the average of 97% for education charities in United Kingdom. Fundraising costs represent 33%. Its revenue is significantly above the peer average of £994K. Create a free GiveRadar account to view the complete financial breakdown with year-over-year trends.

Myeloma UK is classified as an Education organization, registered in United Kingdom. It operates as a Charitable Company. It has £5M in annual revenue.

According to GiveRadar's records, Myeloma UK is registered with the Charity Commission for England and Wales and overseen by the Charity Commission. It reports that 67% of expenses go to programs (the peer average is 97%). GiveRadar provides data for research and does not endorse any organization. A GiveRadar Integrity Assessment reflects how much public data is available, not whether an organization is safe to donate to, so it is always smart to do your own research before giving.

We are here to provide information and support to anyone affected by myeloma. Patients, families, friends, and carers can all draw on our information centre, support groups, discussion forums and Infoline for support when they need it. We invest in research that builds our knowledge of how myeloma develops and progresses. We do this to help everyone working in myeloma better understand and meet the needs of people living with myeloma and to help deliver change. We represent the voices of people affected by myeloma to government, the NHS and the wider healthcare sector to improve access to the latest treatments, remove barriers to prompt diagnosis, and improve the design... Myeloma UK is classified as an education organization registered in United Kingdom. The organization was founded in 1997.

Among education charities registered in United Kingdom: It allocates 67% of expenses to programs, below the peer average of 97%. Its annual revenue of £5M is well above the peer average of £994K.

Myeloma UK is a charitable company limited by guarantee, the most common incorporated form for UK charities. It is registered with both Companies House and the Charity Commission, and must file annual accounts with both regulators. Directors (who are also charity trustees) have limited liability. Its Charity Commission registration number is SC026116.

You can verify Myeloma UK in several ways. First, search the Charity Commission Register at https://register-of-charities.charitycommission.gov.uk/ - every charity registered in England and Wales appears here with its registration number, trustees, governing document, and filed accounts. Because this is a charitable company, you can also check its filings on Companies House (https://find-and-update.company-information.service.gov.uk/). Second, check whether the charity's annual return and accounts are up to date - the Commission flags charities with overdue filings. Third, look for the Fundraising Regulator badge on the charity's website, which signals voluntary compliance with the Code of Fundraising Practice.

Contact Myeloma UK directly for current donation methods. UK charities typically accept online card payments, direct debit, and bank transfer. Many also use platforms such as JustGiving or Charities Aid Foundation (CAF). If you are a UK taxpayer, make sure to tick the Gift Aid box: it lets the charity reclaim 25p from HMRC for every pound you give at no extra cost to you. Higher-rate taxpayers can claim back the difference between basic-rate and their marginal rate through Self Assessment. Payroll Giving (Give As You Earn) lets you donate pre-tax through your employer.

Donations to Myeloma UK are eligible for Gift Aid if you are a UK income-tax or capital-gains-tax payer. Gift Aid adds 25% to your donation at no cost to you (the charity reclaims basic-rate tax from HMRC). Higher-rate and additional-rate taxpayers can also claim back the difference through Self Assessment or by adjusting their PAYE tax code. Gifts of shares, property, or land to charity are free of Capital Gains Tax and can be deducted from your income for Income Tax purposes. Legacy gifts (in your will) reduce the value of your estate for Inheritance Tax and can lower the IHT rate from 40% to 36% if you leave at least 10% to charity.

Myeloma UK is based in Edinburgh in Scotland. The Charity Commission for England and Wales (CCEW) is the primary regulator. Scotland has its own regulator (OSCR), and Northern Ireland has the Charity Commission for Northern Ireland (CCNI). A charity registered with the CCEW may operate across the whole of the UK or internationally.

Myeloma UK was first registered in 1997, making it approximately 29 years old. UK charities must file an annual return with the Charity Commission to remain on the register. A long registration history generally indicates sustained operations and continuous regulatory compliance.